SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $23 | -100.0% | 26,360 | -67.9% | 0.00% | – |
Q3 2022 | $129,000 | -21.8% | 82,204 | 0.0% | 0.00% | – |
Q2 2022 | $165,000 | +108.9% | 82,204 | +122.8% | 0.00% | – |
Q3 2019 | $79,000 | -20.2% | 36,894 | 0.0% | 0.00% | – |
Q2 2019 | $99,000 | -43.4% | 36,894 | 0.0% | 0.00% | – |
Q1 2019 | $175,000 | +96.6% | 36,894 | 0.0% | 0.00% | – |
Q4 2018 | $89,000 | -45.1% | 36,894 | 0.0% | 0.00% | – |
Q3 2018 | $162,000 | -39.1% | 36,894 | 0.0% | 0.00% | – |
Q2 2018 | $266,000 | +40.0% | 36,894 | 0.0% | 0.00% | – |
Q1 2018 | $190,000 | +35.7% | 36,894 | 0.0% | 0.00% | – |
Q4 2017 | $140,000 | +122.2% | 36,894 | 0.0% | 0.00% | – |
Q3 2017 | $63,000 | -39.4% | 36,894 | -28.9% | 0.00% | – |
Q2 2017 | $104,000 | +160.0% | 51,889 | +408.4% | 0.00% | – |
Q1 2017 | $40,000 | -48.7% | 10,206 | -36.3% | 0.00% | – |
Q4 2016 | $78,000 | -61.4% | 16,015 | -38.5% | 0.00% | – |
Q3 2016 | $202,000 | +38.4% | 26,050 | 0.0% | 0.00% | – |
Q2 2016 | $146,000 | +4.3% | 26,050 | 0.0% | 0.00% | – |
Q1 2016 | $140,000 | – | 26,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paloma Partners Management Co | 3,775,000 | $1,359,000 | 0.05% |
Oaktree Fund Advisors, LLC | 66,000 | $23,760 | 0.02% |
GoalVest Advisory LLC | 32,915 | $11,849 | 0.01% |
Houlihan Financial Resource Group, Ltd. | 30,000 | $11 | 0.01% |
Granite Bay Wealth Management, LLC | 22,520 | $8 | 0.01% |
S&T BANK/PA | 38,853 | $14 | 0.00% |
Lattice Capital Management, LLC | 51,800 | $18,648 | 0.00% |
Modus Advisors, LLC | 19,706 | $7,094 | 0.00% |
Crescent Grove Advisors, LLC | 60,000 | $21,600 | 0.00% |
SlateStone Wealth, LLC | 21,433 | $8 | 0.00% |